NCT04693715View on ClinicalTrials.gov

Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 7, 2021

Primary Completion Date

November 8, 2023

Study Completion Date

November 8, 2023

Conditions
Stroke, Ischemic
Interventions
DRUG

RNS60

RNS60 injection solution

DRUG

Placebo

Placebo injection solution

Trial Locations (7)

19104

The Hospital of the University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

37404

Chattanooga Center for Neurologic Research, Chattanooga

60611

Northwestern University, Chicago

77030

Houston Methodist Hospital, Houston

97239

Oregon Health & Science University, Portland

02903

Rhode Island Hospital, Providence

All Listed Sponsors
lead

Revalesio Corporation

INDUSTRY